Programme : Back to Miss Emily Rampling

PamGene’s Kinase activity profiling of tumor tissues of different origin


Many new anti-cancer drugs target kinase activity. Unfortunately, methods to monitor the drug effects at the enzymatic level in patient derived tumor tissue are limited. Here, a novel molecular profiling method for application in biomarker discovery is presented that is based on measuring kinase activities in tumor tissue extracts. An ex vivo activity-based approach which involves assessment of inhibition by a drug of interest, is illustrated for leukemia, locally advances rectal cancer, lung cancer and melanoma tumors. The discovery of prognostic and predictive biomarkers is illustrated with case studies of LARC and breast and lung cancer. Here we present the applicability of this approach for biomarker discovery in multiple tumors of different origin.

Add to favourites

Hosted By
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App
Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
iPhone App
Android App
Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2018